Do patients report quality of life improvements after fitting of their unilateral bone conducting hearing implant?

Meghji, Sheneen; Collett, Anthony R.; Nunney, Ian; Prinsley, Peter; Hanif, J

doi:10.1017/s0022215121000074

Cited by 4 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with our findings, Meghji et al found significantly improved GHSI total and general scores after surgery (23). Interestingly, in their study, the physical health score also increased postoperatively.…”

Section: Discussionsupporting

confidence: 92%

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Caspers

Nelissen

Groenewoud

et al. 2021

Otology &Amp; Neurotology

View full text Add to dashboard Cite

Objective: To evaluate long-term hearing-related quality of life (HRQoL) and device use in bone conduction (BCD) users. Furthermore, to assess differences between indications and changes in HRQoL over time. Study design: Prospective questionnaire survey. Setting: Tertiary referral center. Patients: Seventy-five patients with a percutaneous BCD. Main outcome measures: Glasgow Benefit Inventory (GBI) at 3 and 12 months postoperatively, Glasgow Health Status Inventory (GHSI) preoperatively, and 6 and 36 months postoperatively, device use at 6, 12, and 36 months. Changes over time were assessed and outcomes were compared between indications. Results: After implantation, 97% of all patients reported a positive benefit on the GBI total. The GHSI total had improved with median 15 points (Interquartile range [IQR] 12). At 36 months, median device use was 15 hours/day (IQR 10) and one nonuser was reported. Patients with bilateral hearing loss (BHL) showed greater improvement on the GHSI total (median 18 vs 14, p < 0.0001) and used their devices more frequently (median 16 vs 8 h/day, p < 0.0001) than patients with unilateral HL (UHL). Postoperative GHSI and GBI scores were consistent over time, in the entire patient population and for every indication. Between 6 and 36 months, device use was stable over time, except for patients with single-sided deafness (SSD; median À6.4 h/day, p ¼ 0.009). Conclusion:The BCD improves HRQoL in patients with BHL, in patients with unilateral conductive/mixed hearing loss and in patients with SSD. Patients with BHL experienced a greater improvement in hearing status compared to patients with UHL. Although use decreased over time in SSD patients, device use was high for every indication.

show abstract

Section: Discussionsupporting

confidence: 92%

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Caspers

Nelissen

Groenewoud

et al. 2021

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

“…Health-Related Quality of Life Many studies have shown clinical advantages of the adapted surgical techniques, but there is only little known about the change in patients' HRQoL (16,32,33). This multidomain evaluation of the HRQoL informs about the impact of our primary and secondary outcomes on a patient's functioning in their daily life.…”

Section: Bia400 Versus Ponto Widementioning

confidence: 99%

Long-Term Results of the Linear Incision Technique With Tissue Reduction Versus Tissue Preservation for Inserting Bone-Anchored Hearing Implants: The Ongoing Optimization in Bone Implant Surgery

Lindeboom,

Labbé,

Strijbos

et al. 2024

Otol Neurotol

View full text Add to dashboard Cite

Objective To compare the long-term outcomes of the linear incision technique with tissue reduction (LIT-TR) and the linear incision technique with tissue preservation (LIT-TP) for inserting bone-anchored hearing implants (BAHIs). Study design Single-center retrospective cohort study. Setting Large general teaching hospital. Patients A total of 231 adult patients were included between August 2005 and October 2020, with a minimum follow-up time of 6 months. Intervention The test group received a BAHI using the LIT-TP (N = 147). The control group underwent surgery using the LIT-TR (N = 84). Main outcome measures Soft tissue reactions, skin thickening, postoperative complications (e.g., wound dehiscence), and implant loss were compared between the test and control group. Furthermore, Cochlear Bone Anchored Solutions AB (Mölnlycke, Sweden) and Oticon Medical AB (Askim, Sweden) implants/abutments within the LIT-TP cohort were compared. Validated questionnaires were used to quantify patients' health-related quality of life (HRQoL). Results Significantly more cases with wound dehiscence and adverse soft tissue reactions (Holgers ≥2) were observed in the LIT-TR cohort (p < 0.001). However, the LIT-TP cohort showed significantly more cases with skin thickening (requiring treatment) within the first 2 years after implantation. There were no differences in implant loss rates, overall soft tissue reactions (Holgers >1), and overall HRQoL between the two patient groups. Significant improvement in the patients' HRQoL after implementation of a BAHI was found in both techniques. The Ponto Wide implant/abutment showed less frequent skin thickening (requiring treatment) and fewer soft tissue reactions compared with the BIA400 implant/abutment. Conclusion This large-scale study demonstrates that the LIT-TP shows excellent long-term outcomes, including a low incidence of implant failure.

show abstract

Modern Advances in Bone Conduction–Hearing Devices

Casazza

Kesser

2022

Curr Otorhinolaryngol Rep

View full text Add to dashboard Cite

Do patients report quality of life improvements after fitting of their unilateral bone conducting hearing implant?

Cited by 4 publications

References 29 publications

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Hearing-Related Quality of Life in 75 Patients With a Percutaneous Bone Conduction Device

Long-Term Results of the Linear Incision Technique With Tissue Reduction Versus Tissue Preservation for Inserting Bone-Anchored Hearing Implants: The Ongoing Optimization in Bone Implant Surgery

Modern Advances in Bone Conduction–Hearing Devices

Contact Info

Product

Resources

About